Current partner codePEPTIDESDE
NCT07420127·Phase 4·INTERVENTIONAL

Comparison of Two Different Doses of Phenylephrine on Oxytocin Hemodynamic Effect

Status

Recruiting

Phase

Phase 4

Enrollment

112

Locations

1

Results

Not posted

Publications

0

Study summary

What the protocol is testing.

Cesarean section is one of the commonly performed surgical procedures in the world. Once baby is delivered during the surgical procedure anesthesiologist administer Oxytocin drug through IV cannula which helps the Uterus to contract so that excessive blood loss doesnt occur. But this is associated with fall in blood pressure frequently requiring administration of medications to treat low blood pressure. The most frequently used drug is phenylephrine which can administered along with oxytocin to prevent fall in blood pressure. This study will compare to different doses of Phenylephrine to prevent fall in blood pressure.

Full detailed description

Cesarean section is one of the most commonly performed surgical procedures worldwide. Following delivery of the neonate, oxytocin is routinely administered intravenously to promote uterine contraction and thereby reduce the risk of postpartum hemorrhage. However, oxytocin administration is frequently associated with maternal hypotension, which may necessitate pharmacological intervention. Phenylephrine, a selective α-adrenergic agonist, is commonly used to prevent or treat oxytocin-induced hypotension due to its vasoconstrictive properties. The optimal prophylactic dose of phenylephrine administered concurrently with oxytocin remains uncertain. This study aims to compare two different doses of phenylephrine for the prevention of hypotension following oxytocin administration during cesarean section.

Interventions

Treatment arms and agents.

DRUG

Phenylephrine bolus 75 micrograms

After delivery of Baby during C section, patient will be administered 3 IU of Oxytocin over 3 minutes along with 75 micrograms of Phenylephrine Intravenously.

DRUG

Phenylephrine bolus 50 micrograms

After delivery of Baby during C section, patient will be administered 3 IU of Oxytocin over 3 minutes along with 50 micrograms of Phenylephrine Intravenously.

Timeline

From registration to results.

  1. First posted

    Feb 19, 2026

  2. Study start

    Feb 13, 2026

  3. Primary completion

    Jul 13, 2026

  4. Study completion

    Jul 13, 2026

  5. Results posted

    Not reported

  6. Registry updated

    Feb 24, 2026

Outcomes

What the study measures.

Primary outcomes

Number of Hypotensive episodes

Time frame · Number of hypotensive episodes occuring upto 10 minutes after administration of Oxytocin and Phenylephrine

Hypotension will be defined as fall in Mean Arterial pressure by more than 20% from baseline value.

Secondary outcomes

Rescue Phenylephrine consumed

Time frame · This will be the total amount of Phenylephrine consumed to treat the hypotensive episodes occuring upto 10 minutes after administration of Oxytocin and Phenylephrine

Eligibility

Who can take part.

Minimum age
20 Years
Maximum age
40 Years
Sex
FEMALE
Healthy volunteers
Yes

Inclusion Criteria: \- Females having a singleton pregnancy Patients planned for elective cesarean section under spinal anesthesia Exclusion Criteria: * Patients having a placental abnormality * Patients taking beta-blocker and vasodilator therapy * Patients with hypertensive disorder

Study locations

1 registered sites.

Pakistan. Showing up to 24 locations stored in the fast local snapshot.

Department of Anesthesia, Holy Family Hospital, Rawalpindi

Rawalpindi, Punjab Province, Pakistan

Publications

Results and literature.

No PMID-linked publications were present in this registry snapshot.

Primary links

Continue at the source.

Related trials

More studies on Oxytocin.

Related PeptideStat pages

Put the record in context.

Research pages describe evidence. Vendor pages, where available, describe independently tracked research-product listings and are not clinical recommendations.